Stem Cell Therapy “Rese-Cel” to Be Tested in Trial for Relapsing and Progressive MS
The RESET-MS trial is investigating rese-cel, a CAR T-cell therapy designed to target B-cells in relapsing and progressive multiple sclerosis. This therapy aims to address MS at its immune roots by resetting the system.
